INCYTE GENOMICS INC
S-3/A, EX-23.1, 2000-08-02
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: INCYTE GENOMICS INC, S-3/A, 2000-08-02
Next: INCYTE GENOMICS INC, S-3/A, EX-23.2, 2000-08-02



<PAGE>   1

                                                                    EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in Amendment
No. 1 to the Registration Statement (Form S-3 No. 333-36318) and related
Prospectus of Incyte Genomics, Inc. for the registration of $200,000,000
principle amount of 5.5% Convertible Subordinated Notes Due 2007 and the shares
of Common Stock issuable upon conversion of the Notes and to the incorporation
by reference therein of our report dated January 24, 2000 with respect to the
consolidated financial statements and schedule of Incyte Genomics, Inc. included
in its Annual Report on Form 10-K for the year ended December 31, 1999, filed
with the Securities and Exchange Commission.

                                                               ERNST & YOUNG LLP

Palo Alto, California
July 31, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission